BorchgrevinkC. F. (1960). Long-term anticoagulant therapy in angina pectoris and myocardial infarction. A clinical trial between intensive and moderate treatment. Acta med. scand. Suppl., 359
2.
BjerkelundC. J. (1957a). The effect of long-term treatment with dicoumarol in myocardial infarction. Acta med. scand. Suppl., 330
3.
BjerkelundC. J. (1957b). Myocardial infarction. Transactions of the 6th Congress of the European Society of Haematology, 1957, p. 27. Basel & New York: Karger
4.
BjerkelundC. J. (1961). Proceedings of an international symposium—Anticoagulants and fibrinolysins. Edited by MacMillanR. L.MustardJ. F., p. 266. London: Pitman Medical Publishing
HildenT.IversenK.RaaschouF.SchwartzM. (1961a) Anticoagulants in acute myocardial infarction. Lancet, 2, 327
7.
HildenT.IversenK.RaaschouF.SchwartzM. (1961b) Correspondence—Anticoagulants in acute myocardial infarction. Lancet, 2, 1041
8.
HoneyG. E.TrueloveS. C. (1957). Prognostic factors in myocardial infarction. Lancet, 1, 1155, 1209
9.
Medical Research Council Report (1959). An assessment of long-term anticoagulant administration after cardiac infarction. Brit. med. J., 1, 803
10.
McMichaelJ.ParryE. H. O. (1960). Prognosis and anticoagulant prophylaxis after coronary occlusion. Lancet, 2, 991
11.
MustardJ. F. (1961). Proceedings of an international symposium—Anticoagulants and fibrinolysis. Edited by MacMillanR. L.MustardJ. F., p. 435. London: Pitman Medical Publishing